Neointimal hyperplasia and endothelial function after percutaneous coronary intervention.
作者信息
Sorop O, van Beusekom H M M, van der Giessen W J
出版信息
Neth Heart J. 2006 Oct;14(10):351-353.
Abstract
Percutaneous coronary revascularisation has become much safer and efficacious since its introduction more than 25 years ago. Currently, the need for surgical backup is small and the rate of late complications is lower than 10%. Further improvements are being studied, especially directed towards more biocompatible stents, using pharmacological principles with wider therapeutic windows and enhancing the vascular healing response/reendothelialisation. This article reviews several activities within the ICIN theme group `Vessel Wall'.
摘要
相似文献
1
Neointimal hyperplasia and endothelial function after percutaneous coronary intervention.
Neth Heart J. 2006 Oct;14(10):351-353.
2
A prospective randomised study using optical coherence tomography to assess endothelial coverage and neointimal proliferation at 6-months after implantation of a coronary everolimus-eluting stent compared with a bare metal stent postdilated with a paclitaxel-eluting balloon (OCTOPUS Trial): rationale, design and methods.
EuroIntervention. 2011 May;7 Suppl K:K93-9. doi: 10.4244/EIJV7SKA16.
4
Long-term effects of novel biolimus eluting DEVAX AXXESS plus nitinol self-expanding stent in a porcine coronary model.
Catheter Cardiovasc Interv. 2006 Aug;68(2):271-9. doi: 10.1002/ccd.20848.
5
Early vascular healing after titanium-nitride-oxide-coated stent versus platinum-chromium everolimus-eluting stent implantation in patients with acute coronary syndrome.
Int J Cardiovasc Imaging. 2016 Jul;32(7):1031-9. doi: 10.1007/s10554-016-0871-7. Epub 2016 Apr 13.
7
Electrosprayed Montelukast/poly (lactic-co-glycolic acid) particle based coating: A new therapeutic approach towards the prevention of in-stent restenosis.
Acta Biomater. 2016 Sep 15;42:316-328. doi: 10.1016/j.actbio.2016.07.007. Epub 2016 Jul 7.
8
Evaluation of Early Healing Profile and Neointimal Transformation Over 24 Months Using Longitudinal Sequential Optical Coherence Tomography Assessments and 3-Year Clinical Results of the New Dual-Therapy Endothelial Progenitor Cell Capturing Sirolimus-Eluting Combo Stent: The EGO-Combo Study.
Circ Cardiovasc Interv. 2016 Jul;9(7). doi: 10.1161/CIRCINTERVENTIONS.115.003469.
9
Zedoary Guaiane-Type Sesquiterpenes-Eluting Stents Accelerate Endothelial Healing Without Neointimal Hyperplasia in a Porcine Coronary Artery Model.
J Cardiovasc Pharmacol Ther. 2017 Sep;22(5):476-484. doi: 10.1177/1074248417696819. Epub 2017 Mar 8.
10
Coronary balloon angioplasty, stents, and scaffolds.
Lancet. 2017 Aug 19;390(10096):781-792. doi: 10.1016/S0140-6736(17)31927-X.
本文引用的文献
1
Evaluation of four-year coronary artery response after sirolimus-eluting stent implantation using serial quantitative intravascular ultrasound and computer-assisted grayscale value analysis for plaque composition in event-free patients.
J Am Coll Cardiol. 2005 Nov 1;46(9):1670-6. doi: 10.1016/j.jacc.2005.06.076. Epub 2005 Oct 10.
2
Rapamycin, but not FK-506, increases endothelial tissue factor expression: implications for drug-eluting stent design.
Circulation. 2005 Sep 27;112(13):2002-11. doi: 10.1161/CIRCULATIONAHA.105.569129. Epub 2005 Sep 19.
3
In vivo cell seeding with anti-CD34 antibodies successfully accelerates endothelialization but stimulates intimal hyperplasia in porcine arteriovenous expanded polytetrafluoroethylene grafts.
Circulation. 2005 Jul 5;112(1):12-8. doi: 10.1161/CIRCULATIONAHA.104.504407. Epub 2005 Jun 27.
4
Four-year angiographic and intravascular ultrasound follow-up of patients treated with sirolimus-eluting stents.
Circulation. 2005 May 10;111(18):2326-9. doi: 10.1161/01.CIR.0000164271.01172.1A. Epub 2005 Apr 25.
5
Late thrombosis in drug-eluting coronary stents after discontinuation of antiplatelet therapy.
Lancet. 2004;364(9444):1519-21. doi: 10.1016/S0140-6736(04)17275-9.
6
Localized hypersensitivity and late coronary thrombosis secondary to a sirolimus-eluting stent: should we be cautious?
Circulation. 2004 Feb 17;109(6):701-5. doi: 10.1161/01.CIR.0000116202.41966.D4. Epub 2004 Jan 26.
7
Long-term endothelial dysfunction after coronary artery stenting.
J Am Coll Cardiol. 1999 Nov 15;34(6):1675-9. doi: 10.1016/s0735-1097(99)00411-8.
8
Long-term endothelial dysfunction is more pronounced after stenting than after balloon angioplasty in porcine coronary arteries.
J Am Coll Cardiol. 1998 Oct;32(4):1109-17. doi: 10.1016/s0735-1097(98)00348-9.
9
Increasing arterial wall injury after long-term implantation of two types of stent in a porcine coronary model.
Eur Heart J. 1998 Apr;19(4):601-9. doi: 10.1053/euhj.1997.0753.
10
Marked inflammatory sequelae to implantation of biodegradable and nonbiodegradable polymers in porcine coronary arteries.
Circulation. 1996 Oct 1;94(7):1690-7. doi: 10.1161/01.cir.94.7.1690.
Zotero 插件